Don't miss our holiday offer - up to 50% OFF!
Latisse Eyelash Serum 3ml
70,00 €
Latisse® is a prescription ophthalmic solution containing bimatoprost 0.03%, used to enhance eyelash growth (length, thickness, and darkness). It is manufactured by Allergan (AbbVie) and is the only FDA-approved treatment specifically indicated for hypotrichosis of the eyelashes.
Latisse® is a prescription ophthalmic solution containing bimatoprost 0.03%, used to enhance eyelash growth (length, thickness, and darkness). It is manufactured by Allergan (AbbVie) and is the only FDA-approved treatment specifically indicated for hypotrichosis of the eyelashes. It is intended only for use under medical supervision, as it is applied to the upper eyelid margin. It does not act as a cosmetic serum or hair conditioner, but as a prostaglandin analog medication that stimulates hair growth cycles.
Packaging
Typical presentation:
- 1 × 3 mL bottle (commonly labeled for ~60 applications)
- Sterile ophthalmic applicators included
- Multi-dose solution used daily over several weeks
(Some listings may describe “1.0 mL equivalent” depending on distributor packaging terminology, but standard Latisse is 3 mL.)
Composition
Each mL contains:
- Bimatoprost 0.03% (0.3 mg/mL)
- Benzalkonium chloride (preservative)
- Sodium chloride
- Sodium phosphate buffer
- Purified water
Safety Information
Must only be used under medical guidance.
Possible side effects:
- Eye redness
- Itching or irritation
- Darkening of eyelid skin
- Increased iris pigmentation (rare but permanent if it occurs)
- Hair growth in unintended areas if misapplied
Contraindications may include:
- Hypersensitivity to bimatoprost
- Active eye infections
- History of uveitis or certain ocular conditions (doctor dependent)
Mechanism of Action
Latisse works by:
- Extending the anagen (growth) phase of eyelash follicles
- Increasing the number of hairs in the active growth phase
- Enhancing hair shaft thickness
- Increasing pigmentation by stimulating melanogenesis
Results develop gradually with consistent application.
Product Features
- Bimatoprost 0.03% prostaglandin analog
- Clinically proven eyelash growth stimulation
- Once-daily topical application
- Prescription-only ophthalmic solution
- Gradual, progressive improvement
Expected Results
Typical timeline:
- 4 weeks: early lash improvement
- 8 weeks: noticeable length and fullness
- 12–16 weeks: full effect
Results:
- Longer lashes
- Thicker lashes
- Darker appearance
Results are maintained only with continued use.
Duration
- Effects diminish gradually after discontinuation
- Maintenance use required for sustained results
Advantages
- Clinically proven efficacy
- FDA-approved eyelash growth treatment
- Non-invasive cosmetic enhancement
- Improves all lash parameters (length, thickness, color)
Application Method
- Applied once daily in the evening
- Using sterile applicators to the upper eyelid margin only
- Excess solution should be avoided to prevent unwanted hair growth
Important:
- Do not apply to lower lash line
- Do not reuse applicators
- Contact lenses must be removed before use
Common Treatment Use
Latisse is used for:
- Eyelash hypotrichosis (inadequate lashes)
- Cosmetic lash enhancement
- Post-lash thinning conditions (non-scarring causes)
| Brand | Latisse |
|---|---|
| Package Content | 1 bottle x 3ml per pack, approx. 60 applications |
| Manufacturer | Allergan |
| Country of origin | United States |
| Import | This product is from the European Community (EC) |
| CE-mark | This product is regulated as a medicinal product and does not carry a CE-mark |


Reviews
There are no reviews yet.